ARCHIVES

ODAC To Advise FDA on First Biosimilars Application Jan. 7

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

DCT Board Oks Recompetition Of Master Agreement For BRM Trials

February 4, 1983

Seattle Institutions Win $16 Million In Grants For Comparative Effectiveness Research

October 16, 2009

NTP Board Gives Concept Approvals

December 4, 1981

New Community Center Assnt. Determined To Improve Quality Of Care “With Or Without” NCI Assistance

September 27, 1974

Clinton Proposes Increase For Science And Technology.

February 4, 2000

In Brief: Lichter, Bailes Lead ASCO; NCI Names Vande Woude Basic Sciences Director

May 22, 1998